Measurement of serum proSurfactant protein-B levels – A novel biomarker of an impaired diffusion?

F. Trinkmann, J. Detzel, D. Hütter, U. Hoffmann, M. Neumaier, M. Borggrefe, J. Saur (Mannheim, Germany)

Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Session: Novel biomarkers and old parameters in clinical management of lung diseases
Session type: Poster Discussion
Number: 410
Disease area: Airway diseases, Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Trinkmann, J. Detzel, D. Hütter, U. Hoffmann, M. Neumaier, M. Borggrefe, J. Saur (Mannheim, Germany). Measurement of serum proSurfactant protein-B levels – A novel biomarker of an impaired diffusion?. Eur Respir J 2013; 42: Suppl. 57, 410

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Concentration of exhaled endogenous particles in relation to peripheral airway dysfunction
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Circulating C-reactive protein level is negatively correlated with lung volume
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Increased circulating levels of α1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs
Source: Eur Respir J 2001; 17: 1105-1111
Year: 2001



Surfactant protein A in particles in exhaled air (PEx) – A better reflection of small airways in comparison to bronchoalveolar lavage and serum?
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

The impact of gas analysis technique on the measurement of single breath gas transfer (TLCO)
Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement
Year: 2015


Development of a method for quantification of phosphatidylcholine in exhaled breath
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Infant lung function testing: First in vivo report of a novel inert gas washout method to measure LCI
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Human breath analysis supports the existence of individual phenotypes
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013


Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Detection of angiogenesis, antiangiogenesis and hypoxia related molecules in plasma and exhaled breath condensate (EBC): evaluation of potential biomarkers
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009

Identification of MDA associated clusters in exhaled breath samples of patient measurements from GC-IMS spectra
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

Optimal use of gas transfer values in detecting pulmonary vascular involvement in sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Potential markers of the progression of CRF in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015

Assessment of the Japanese reference value of a new portable instrument for the diffusing capacity of the lungs for carbon monoxide
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015

Elevated serum iron as a marker for spirometric resistance to cigarette smoke: The Takahata study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Airway: blood glucose ratio. A new pulmonary biomarker?
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006

Measurements of carbon monoxide (CO) in exhaled air and calculation of alveolar-capillary membrane diffusion capacity
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013

Exhaled surfactant protein A and albumin in a healthy Swedish population
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Impact of the choice of CO and NO conductance values on the interpretation of CO and NO diffusion capacities
Source: Annual Congress 2013 –Respiratory physiology in health and disease
Year: 2013